Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenJared M. Baeten, Connie Celum, Jordan W. Tappero et al.|New England Journal of Medicine|2012Cited by 3.3k
Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 YearsSharon Nachman, H. N. Ndiweni, Naiyu Zheng et al.|Clinical Infectious Diseases|2013Cited by 60
Oral Ganciclovir in Children: Pharmacokinetics, Safety, Tolerance, and Antiviral EffectsLisa M. Frenkel, Stephen A. Spector, Edmund V. Capparelli et al.|The Journal of Infectious Diseases|2000Cited by 47